Problems in the prescription of medicines in Venezuela
Keywords:
Prescription, medications, regulations, availability, adverse effects, bacterial resistance, Pharmacovigilance.Abstract
In recent years, Venezuelans have faced various kinds of problems related to the health situation. Among them, problems in prescription and acquisition of medicines. This publication will discuss important aspects for the correct prescription and obtention of medicines, which, in turn, should be the culmination of the excellent medical care that has always characterized our country but that today, unfortunately, has become a very disgraced and sad situation. Prescription and acquisition of medicines can be hindered by various inconveniences, among which we can consider those that are related to the product itself, to the prescriber and the client, to the regulations in force in our country and to the availability in authorized centers for sale. As a result of an inadequate prescription and consumption of medications, very serious problems can arise, among which, in the field of anti-infectives, bacterial resistance should be highlighted. In the field of drugs for the treatment of pain, anxiety and insomnia, the possibility of diverse addictions. Proper prescription of medicaments entails the need to know, along with their beneficial and therapeutic effects, the possibility of adverse effects and interactions. All health prescribers must know the basics of Pharmacovigilance, which allow to know the true risk-benefit balance of drugs, so we make a brief mention of it at the end of this presentation.Downloads
References
Díaz Bruzual A, López Loyo E, editores. Dres. Leopoldo Briceño-Iragorry, Marino J. González Reyes La salud pública en Venezuela, su evolución histórica, estado actual y propuestas Colección Razetti. Capítulo 11 Volumen XX. Caracas: Editorial Ateproca; 2017. p361-399.
Bonvecchio A, Becerril-Montekio V, Carriedo-Lutzenkirchen A, Landaeta-Jiménez M. Sistema de salud de Venezuela. Salud Publica Mex 2011; 53 supl. 2: S275-S286.
Caires W. Investigación Epidemiológica y Medicamentos: Farmacoepidemiología. Revista del Instituto Nacional de Higiene “Rafael Rangel”, 2017; 48 (1-2).
Nontaya N, Parinya K, Sirimas K, Niwat S, Thachanan K, Kanyarat K, et al. HLA Pharmacogenetic Markers of Drug Hypersensitivity in a Thai Population Front. Genet. 2018; 9:277. doi: 10.3389/fgene.2018.00277
Anon. Drugs Past Their Expiration Date. The Medical Letter on Drugs and Therapeutics. 2009; 51:101-102. Accessed May 29, 2018 at https://misuse.ncbi.nlm.nih.gov/error/abuse.shtml
American Medical Association. "Pharmaceutical Expiration Dates." Report 1 of the Council on Scientific Affairs (A-01). July 25, 2001.
FDA. Expiration Dating Extension. [Internet]. Accessed May 29, 2019, at: www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/expiration-dating-extension
Lyon RC, Taylor JS, Porter DA, et al. Stability profiles of drug products extended beyond labeled expiration dates. J Pharm Sci 2006; 95: 1549-60. Accessed May 29, 2019 at https://misuse.ncbi.nlm.nih.gov/error/abuse.shtml
Robert L, Diego L, Casanovas M, Pellicer A, Ribes E, Rodríguez G. Carga anticolinérgica: ¡Pensemos en ella! Aspectos de seguridad más allá de la visión borrosa y la sequedad de boca BIT. 2018; 29(8).
Gray SL, Hanlon JT. Anticholinergic medication use and dementia: latest evidence and clinical implications. Ther Adv Drug Saf. 2016; 7(5) 217–224. DOI: 10.1177/2042098616658399
Herrera Comoglio R, et al. coordinado por Raquel Herera con prólogo de Lindquist Marie comoglio. Farmacovigilancia, hacia una mayor seguridad en el uso de los medicamentos. 1ª ed. Córdoba – Raquel Herrera Comoglio Ediciones; 2012.
How to Cite
Issue
Section
License
Usted es libre de:
- Compartir — copiar y redistribuir el material en cualquier medio o formato
- Adaptar — remezclar, transformar y construir a partir del material
- para cualquier propósito, incluso comercialmente.
Bajo los siguientes términos:
-
Atribución — Usted debe dar crédito de manera adecuada, brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
- No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.